Does brigatinib need to be taken for a long time?

Brigatinib (Brigatinib) usually needs to be taken long-term because non-small cell lung cancer (NSCLC), especially anaplastic lymphoma kinase (ALK) positive type of lung cancer, is a chronic and rapidly progressive disease. Brigatinib helps control the disease by inhibiting the activity of ALK gene, preventing the growth and spread of cancer cells. Therefore, to maintain the effects of treatment and prevent cancer from coming back, patients often need to continue taking brigatinib until their disease progresses or they become intolerant to the drug.

During long-term treatment with brigatinib, regular medical examinations and monitoring are very important. These tests include imaging tests, blood tests, electrocardiograms, etc., to evaluate the efficacy of the drug and monitor potential adverse reactions. Based on the test results, the doctor may adjust the drug dosage to ensure the best therapeutic effect and patient safety. If serious side effects occur, your doctor may consider temporarily stopping the medication or adjusting the dose.

Research shows that long-term use of brigatinib can significantly delay the progression ofALK-positive non-small cell lung cancer and improve patients' quality of life. Even when your disease is stable or in remission, continuing to take brigatinib (brigatinib) can help prevent the cancer from coming back or spreading further. Continuous treatment not only helps control the disease but also prolongs patients' progression-free survival and overall survival. Therefore, unless there is a clear medical reason, patients should insist on taking brigatinib (brigatinib) for a long time as directed by their doctor.

Treatment regimens with brigatinib should be individually tailored to the patient's specific circumstances. The patient's health, severity of illness, response to the drug, and possible adverse reactions may affect when and how much brigatinib should be taken. During the treatment process, the doctor will work closely with the patient to regularly evaluate the treatment effect and adjust the treatment plan as needed. Patients should actively communicate with their doctors and report any discomfort or abnormalities so that treatment strategies can be adjusted in a timely manner to ensure the best treatment effect and safety.